Guangzhou Wondfo Biotech Co Ltd (300482) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Guangzhou Wondfo Biotech Co Ltd (300482) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥116.99 Million ≈ $17.12 Million USD) by net assets (CN¥5.56 Billion ≈ $813.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guangzhou Wondfo Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Guangzhou Wondfo Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300482 total liabilities for a breakdown of total debt and financial obligations.

Guangzhou Wondfo Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Wondfo Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Via Transportation, Inc. NASDAQ:VIA	-0.001x
Baoding Heavy Industry Co Ltd SHE:002552	0.056x
Bolsa Mexicana de Valores S.A.B. de C.V MX:BOLSAA	0.041x
Shanghai STEP Electric Corp SHE:002527	0.009x
Kuaijishan Shaoxing Rice Wine SHG:601579	-0.024x
Shanghai Yaoji Playing Card Co Ltd SHE:002605	0.046x
Deep Yellow Ltd AU:DYL	-0.004x
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros MC:LDA	0.278x

Annual Cash Flow Conversion Efficiency for Guangzhou Wondfo Biotech Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Guangzhou Wondfo Biotech Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.65 Billion ≈ $826.81 Million	CN¥361.71 Million ≈ $52.93 Million	0.064x	-23.90%
2023-12-31	CN¥4.61 Billion ≈ $675.26 Million	CN¥388.19 Million ≈ $56.80 Million	0.084x	-77.31%
2022-12-31	CN¥4.54 Billion ≈ $663.99 Million	CN¥1.68 Billion ≈ $246.15 Million	0.371x	+95.36%
2021-12-31	CN¥3.50 Billion ≈ $512.76 Million	CN¥664.93 Million ≈ $97.30 Million	0.190x	-46.50%
2020-12-31	CN¥2.99 Billion ≈ $438.06 Million	CN¥1.06 Billion ≈ $155.38 Million	0.355x	+181.66%
2019-12-31	CN¥2.46 Billion ≈ $360.06 Million	CN¥309.86 Million ≈ $45.34 Million	0.126x	+9.42%
2018-12-31	CN¥2.15 Billion ≈ $314.82 Million	CN¥247.61 Million ≈ $36.23 Million	0.115x	-18.89%
2017-12-31	CN¥1.19 Billion ≈ $174.13 Million	CN¥168.85 Million ≈ $24.71 Million	0.142x	+8.28%
2016-12-31	CN¥854.75 Million ≈ $125.08 Million	CN¥112.01 Million ≈ $16.39 Million	0.131x	-30.35%
2015-12-31	CN¥700.64 Million ≈ $102.53 Million	CN¥131.81 Million ≈ $19.29 Million	0.188x	-43.56%
2014-12-31	CN¥313.43 Million ≈ $45.86 Million	CN¥104.47 Million ≈ $15.29 Million	0.333x	-20.24%
2013-12-31	CN¥241.47 Million ≈ $35.33 Million	CN¥100.91 Million ≈ $14.77 Million	0.418x	+1.91%
2012-12-31	CN¥182.48 Million ≈ $26.70 Million	CN¥74.84 Million ≈ $10.95 Million	0.410x	+148.81%
2011-12-31	CN¥144.61 Million ≈ $21.16 Million	CN¥23.83 Million ≈ $3.49 Million	0.165x	--

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices

Market Cap

$1.25 Billion

CN¥8.56 Billion CNY

Market Cap Rank

#8139 Global

#2057 in China

Share Price

CN¥18.29

Change (1 day)

-1.93%

52-Week Range

CN¥17.43 - CN¥25.56

All Time High

CN¥92.01